Por Vicente Guillem, President of the ECO and Jefe Foundation of the Department of Oncology of the Valencian Institute of Oncology
Last July, the Congress of Deputies published the Dictations of the Commission for the Social and Economic Reconstruction of Spain, which in its Article 47.2 determines that all those activities of investigation and training which, whether directly or indirectly, are financed by industry, are prohibited. Without embarrassment, we find in a context where 25 on the basis of the clinical investigation that has taken place in our country in the last few years is academic (non-commercial), and the inversion that the SNS in the Continuing Medical Training cover the minimum training needs of the sanitary professionals.
Of the various medical organizations such as the Spanish Society of Medical Oncology (SEOM), the Federation of Scientific-Medical Associations of Spain (FACME) or the ECO Foundation, of which it is president, we review the values of transparency, independence and rigorous rigor that our ethical codes rig and, therefore, the form in which we relate to industry. Hecho, these collaborations were allowed to record great advances in research and technological development, which he embarked on a paradigmatic transformation of Oncology in the last few years.
No debemos olvidar que cancer is a disease with a high incidence about the population and what we have so much to discover. The dynamism of this area surpasses that, in 2009, the ECO Foundation assumes the mission of guaranteeing excellence in oncological assistance in cancer cancers using the efforts of experts in this field. Since then, we have been developing an extensive activity of training, teaching, research and assistance in the field of Oncology, for get rid of the ultimate advancements that are produced in the specialty. Activities that could not be more lucrative are thanks to the contribution of the pharmaceutical industry.
In the last years, the acquaintances that he brought about the physiopathology of our cancer were allowed individualize each treatment that a patient receives Thank you to the biomarkers of respite and evolution of medicine. También hemos conseguido develop new medicines, such as advanced therapies or personalized medicine, with action mechanisms that impact a concrete therapeutic diana.
In terms of sanitary technology, it is very likely that it is available today with effective diagnostic methods and new administration formulas that prevent significant risks to patients. For this reason, thanks to the Continuing Medical Training, he then proceeded to change the course of the nurses, preventive or diagnostic methods of precautionary measures.
If we need these collaborations with you, we must seriously compromise the training that our sanitary professionals receive, as well as being treated in an assisted living environment that cares for patients, as well as involving the Medical Oncology of our country.
In order to achieve an idea of the magnitude of what the Independent (Academic) Research is doing in our country “More than 55,000 patients were included in clinical trials, and more than 125,000 in other basic and translational research projects, epidemiological studies, pharmaconomic, observational, and tumor and patient records.”. This is what SEOM indicated in various communications.
In this point, fundamental results result luchando para que the inversion in investigation and education of the health care professionals aumente, is that the insufficiency of public recourse is that there is a teaching assignment for the professionals that we dedicate to Medicine and, more specifically, to the oncology department. Salvador Illa, former Minister of Health, responds a la carta del president of SEOM, el Dr. Álvaro Rodríguez-Lescure, compromises the dose and processes the process of relaxation and the impulso of participation in the distribution agents and the configuration of the conditions of the financial privada and the formación continuada, la investigación y la educación sanitaria.
From the ECO Foundation, we will continue to collaborate and work on the scientific disclosure of all new water products that can be surpassed in our specialty, as in the area of identification of those lagoons that can exist in determined areas, with the aim of contributing to enhance the experience of patients.